Literature DB >> 11755125

Role of cytokines in the lipopolysaccharide-evoked depression of cytochrome P450 in the brain and liver.

T E Nicholson1, K W Renton.   

Abstract

A role for cytokines as mediators of the depression in cytochrome P450 activity in brain and liver during CNS inflammation is proposed. Lipopolysaccharide (LPS) was given directly into the lateral ventricle of the brain to mimic a localized CNS infection. CYP1A activity and protein in both brain and liver were depressed in response to this treatment. The administration of the pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interferon-gamma (IFN-gamma) directly into the lateral ventricle emulated the effects of LPS on CYP1A activity only in the brain. In contrast, these centrally administered cytokines did not produce a concomitant loss of CYP1A activity in the liver. Significant levels of several cytokines (TNF-alpha, IL-1beta, and IFN-gamma) were produced in the serum of animals following intracerebroventricular (i.c.v.) administration of LPS. This production of peripheral cytokines by LPS could not be mimicked by the i.c.v. injection of IL-1beta or TNF-alpha. These results suggest that induction of cytokines in the brain may play a direct role in the depression of CYP1A activity in the CNS following the administration of LPS into the lateral ventricle. The production of cytokines within the brain does not appear to participate in the signaling process in the brain that leads to the concomitant loss of CYP1A activity in the liver. The subsequent production of cytokines in peripheral tissues, however, does appear to play a role in the loss of cytochrome P450 in the liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755125     DOI: 10.1016/s0006-2952(01)00859-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

Authors:  Kerry B Goralski; Georgy Hartmann; Micheline Piquette-Miller; Kenneth W Renton
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

2.  The potential role of transcription factor aryl hydrocarbon receptor in downregulation of hepatic cytochrome P-450 during sepsis.

Authors:  Mian Zhou; Subir R Maitra; Ping Wang
Journal:  Int J Mol Med       Date:  2008-04       Impact factor: 4.101

Review 3.  The aryl hydrocarbon receptor complex and the control of gene expression.

Authors:  Timothy V Beischlag; J Luis Morales; Brett D Hollingshead; Gary H Perdew
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

4.  The role of hepatic cytochrome P-450 in sepsis.

Authors:  Asha Jacob; Mian Zhou; Rongqian Wu; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2009-08-25

Review 5.  Disease-drug and drug-drug interaction in COVID-19: Risk and assessment.

Authors:  Devendra Kumar; Neerja Trivedi
Journal:  Biomed Pharmacother       Date:  2021-04-27       Impact factor: 7.419

Review 6.  Microglia Involves in the Immune Inflammatory Response of Poststroke Depression: A Review of Evidence.

Authors:  Weili Xia; Yong Xu; Yuandong Gong; Xiaojing Cheng; Tiangui Yu; Gongchang Yu
Journal:  Oxid Med Cell Longev       Date:  2022-08-02       Impact factor: 7.310

7.  Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression.

Authors:  Arif Demirdaş; Mustafa Nazıroğlu; Gülin Özdamar Ünal
Journal:  Metab Brain Dis       Date:  2016-07-20       Impact factor: 3.584

8.  Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.

Authors:  Mahmoud A El-Ghiaty; Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Med Hypotheses       Date:  2020-06-26       Impact factor: 1.538

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.